Here are the week’s top stories: Off-Label Marketing: Jack’s Posterous has a recount of recent off-label marketing fines paid by drug dealers (oops, I mean manufacturers). “As long as off-label promotion is more profitable than the fines for punishing off-label...

Posted in Drug Recall Lawyer Blog on June 8, 2010 8:43 AM

The results of a new study are out, which show the dangers Zocor in high doses or in conjunction with other drugs. Zocor is indicated as one component of multiple risk factor intervention for people at significantly increased risk of...

Posted in Drug Recall Lawyer Blog on March 23, 2010 9:47 AM

Drug Recall Lawyer Blog Round-Up (03-22-10) Here are this week’s stories: Avandia: The MayoClinic investigated who authored articles supporting Avandia in medical journals, and discovered that 90% had ties to the manufacturer, GlaxoSmithKline (HT: FiercePharma). Seroquel: Trial number one is...

Posted in Drug Recall Lawyer Blog on March 22, 2010 10:47 AM